Right bundle branch block predicts appropriate implantable cardioverter defibrillator therapies in patients with non-Iischemic dilated cardiomyopathy and a prophylactic implantable cardioverter defibrillator

Background: the benefit of prophylactic implantable cardioverter defibrillators (ICDs) in patients with severe systolic dysfunction of non-ischemic origin is still unclear, and the identification of patients at risk for sudden cardiac death remains a major challenge. Aims/Methods: we retrospectively...

Descripción completa

Detalles Bibliográficos
Autores: Jiménez-Blanco Bravo, Marta, Alonso Salinas, Gonzalo Luis, Parra Esteban, Carolina, Toquero Ramos, Jorge, Amores Luque, Miguel, Zamorano Gómez, José Luis, García-Izquierdo, Eusebio, Álvarez-García, Jesús, Fernández Lozano, Ignacio, Castro Urda, Víctor
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2024
País:España
Institución:Universidad Pública de Navarra
Repositorio:Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
OAI Identifier:oai:academica-e.unavarra.es:2454/52374
Acceso en línea:https://hdl.handle.net/2454/52374
Access Level:acceso abierto
Palabra clave:Implantable cardioverter defibrillator
Non-ischemic dilated cardiomyopathy
Primary prevention
Right bundle branch block
Sudden cardiac death
Descripción
Sumario:Background: the benefit of prophylactic implantable cardioverter defibrillators (ICDs) in patients with severe systolic dysfunction of non-ischemic origin is still unclear, and the identification of patients at risk for sudden cardiac death remains a major challenge. Aims/Methods: we retrospectively reviewed all consecutive patients with non-ischemic dilated cardiomyopathy (NICM) who underwent prophylactic ICD implantation between 2008 and 2020 in two tertiary centers. Our main goal was to identify the predictors of appropriate ICD therapies (anti-tachycardia pacing [ATP] and/or shocks) in this cohort of patients. Results: a total of 224 patients were included. After a median follow-up of 51 months, 61 patients (27.2%) required appropriate ICD therapies. Patients with appropriate ICD therapies were more frequently men (87% vs. 69%, p = 0.006), of younger age (59 years, (53-65) vs. 64 years, (57-70); p = 0.02), showed more right bundle branch blocks (RBBBs) (15% vs. 4%, p = 0.007) and less left bundle branch blocks (LBBBs) (26% vs. 47%, p = 0.005) in the ECG, and had higher left ventricular end-diastolic (100 mL/m2, (90-117) vs. 86, (71-110); p = 0.011) and systolic volumes (72 mL/m2, (59-87) vs. 61, (47-81), p = 0.05). In a multivariate competing-risks regression analysis, RBBB (HR 2.26, CI 95% 1.02-4.98, p = 0.043) was identified as an independent predictor of appropriate ICD therapies. Conclusion: RBBBs may help to identify patients with NICM at high risk of ventricular arrhythmias and requiring ICD intervention.